Clinical features of steroid-resistant patients with severe steroid-dependent bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 133s Year: 2004
The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 32s Year: 2003
The genetic markers (HLA system) of steroid-resistance in severe bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006
Risk of bronchiectasis in bronchial asthma: steroid-dependent versus non-steroid-dependent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
The immunological features of the severe steroid-resistant asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
Treating rhinitis in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001
Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012
Gene expression in bronchial biopsies from subjects with persistent asthma and asthma in remission Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
Lymphocyte subpopulations in serum in patients with nonallergic asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 288s Year: 2006
The effectiveness of omalizumab in steroid-dependent asthma patients Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020
Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002
Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Small airways disease evaluation in patients with mild/moderate asthma and correlation with bronchial hyperresponsiveness and disease control Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018
The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002
A comparative analysis of the non-specific bronchial hyperreactivity in patients with newly discovered bronchial asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 235s Year: 2006